Estudio de Patología Respiratoria Aguda con Ultrasonidos (EPRAUS)
- Campos Caubet L 1
- Campo Linares R 2
- Ferreiro Gómez M 3
- Álvarez Gregori JA 4
- García Suárez I 5
- Nogué Bou R 6
- Zafra Sánchez JJ 7
- Chenayeb J 8
- 1 Servicio de Urgencias, Hospital Comarcal Sierrallana, Torrelavega, Cantabria, España.
- 2 Servicio de Urgencias, Hospital Santa Bárbara, Soria, España.
- 3 Servicio de Urgencias, Hospital de A Coruña, La Coruña, España.
- 4 Servicio de Urgencias, Hospital General Universitario Nuestra Señora del Prado, Talavera de la Reina, Toledo, España.
- 5 Servicio de Urgencias, Hospital San Agustín, Avilés, España.
- 6 Servicio de Urgencias, Hospital Santa María, España.
- 7 Servicio de Urgencias, Hospital San Eloy, Bilbao, España.
- 8 Servicio de Urgencias Hospital Clínico de Valladolid, Valladolid, España.
ISSN: 2951-6552, 2951-6544
Ano de publicación: 2023
Volume: 2
Número: 2
Páxinas: 78-84
Tipo: Artigo
Outras publicacións en: Revista Española de Urgencias y Emergencias
Obxectivos de Desenvolvemento Sustentable
Resumo
OBJECTIVES. To assess the value of emergency department use of lung ultrasound imaging to predict prognosis in COVID-19 diagnosed by rapid antigen or polymerase chain reaction testing in in relation to predicting changes in clinical variables reflecting severity: intensive care unit (ICU) admission, need for invasive mechanical ventilation (MV), or noninvasive MV, death, or hospital stay of more than 14 days. MATERIAL AND METHODS. Prospective observational multicenter study recruiting patients during 3 months in 2020 (April 1 to July 1). RESULTS. Data for 400 patients were analyzed; 226 were men (56.5%, the mean age was 62.3 years (95% CI, 60.1-64.4 years, and 263 patients (70.8%; 95% CI, 66.1%-75%) had positive test results for COVID-19. The clinical course of 93 of these patients (32.9%; 95% CI, 27.7%-38.5%) resulted in serious illness (ICU admission, invasive or noninvasive MV, death, or hospital stay over 14 days). Abnormal lung ultrasound findings correlated with severity. A noteworthy ultrasound finding was of anterior confluent B-lines, which increased the probability of disease progression 9-fold (odds ratio, 9.41; 95% CI, 4.71-18.78), as well as the likelihood of seeing the clinical outcomes studied. Six of the clinical outcome associations were significant. CONCLUSIONS. A lung ultrasound score is a good predictor of severity, but it should be used in conjunction with clinical variables and physical examination. In lung disease in the context of COVID-19, the ultrasound score correlates significantly with clinical variables whose complex associations we were able to simplify in a QR (quick response) code for use in emergency departments.